Cite
Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation.
MLA
Anliker, Markus, et al. “Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation.” Journal of Immunology (Baltimore, Md. : 1950), vol. 208, no. 5, Mar. 2022, pp. 1248–58. EBSCOhost, https://doi.org/10.4049/jimmunol.2100031.
APA
Anliker, M., Drees, D., Loacker, L., Hafner, S., Griesmacher, A., Hoermann, G., Fux, V., Schennach, H., Hörtnagl, P., Dopler, A., Schmidt, S., Bellmann-Weiler, R., Weiss, G., Marx-Hofmann, A., Körper, S., Höchsmann, B., Schrezenmeier, H., & Schmidt, C. Q. (2022). Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation. Journal of Immunology (Baltimore, Md. : 1950), 208(5), 1248–1258. https://doi.org/10.4049/jimmunol.2100031
Chicago
Anliker, Markus, Daniela Drees, Lorin Loacker, Susanne Hafner, Andrea Griesmacher, Gregor Hoermann, Vilmos Fux, et al. 2022. “Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation.” Journal of Immunology (Baltimore, Md. : 1950) 208 (5): 1248–58. doi:10.4049/jimmunol.2100031.